Health Canada approves Paladin Labs Digifab
DigiFab is an antidote for digoxin toxicity. It works by binding to digoxin and preventing it from working in the body. Paladin Labs president and CEO Jonathan Ross
WuXi XDC Cayman has signed an agreement to provide Ona Therapeutics with an exclusive global licence to its WuXiTecan-2 payload-linker technology platform for the development of an antibody-drug conjugate (ADC) candidate.
PureNano combines a machine with expert process development to obtain smaller and more consistent particle sizes for several applications including pharmaceutical and energy industries. The PureNano Continuous Crystallizer